High dose induction therapy with interferon alpha followed by combination therapy for naive hepatitis C patients - Results of a multicenter randomized controlled study.

被引：0
|
作者：
Kaiser, S
Kreysel, C
Zeitz, M
Schneider, W
Gregor, M
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Univ Homburg, D-6650 Homburg, Germany
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1608
引用
收藏
页码：561A / 561A
页数：1
相关论文
共 50 条
  • [41] Effectiveness of Combination Therapy with Tocilizumab and Low-Dose Prednisolone as an Induction Therapy in Biologics-Naive Patients with Rheumatoid Arthritis: A Prospective, Randomized, Controlled, Open-Label, Multicenter Study
    Yokota, Kazuhiro
    Nagasawa, Hayato
    Akiyama, Yuji
    Mimura, Toshihide
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2830 - 2831
  • [42] PHLEBOTOMY FOLLOWED BY ALPHA-INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
    YANO, M
    KAKUMU, S
    HAYASHI, H
    TAKIKAWA, T
    NISHIMURA, N
    HEPATOLOGY, 1995, 22 (04) : 51 - 51
  • [43] Induction treatment with combination therapy results in a lower relapse rate in naive patients with chronic hepatitis C.
    Rothstein, KD
    Pena, RE
    Suvannasankha, A
    DiGregorio, K
    Manzarbeitia, C
    Reich, DJ
    Bond, K
    Gross, F
    Shaw, E
    Peikin, S
    Mushnick, A
    Munoz, SJ
    HEPATOLOGY, 2000, 32 (04) : 560A - 560A
  • [44] Combination of interferon induction therapy and ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Munda-Steindl, P
    Hegenbarth, K
    Gangl, A
    Vogel, W
    HEPATOLOGY, 2001, 34 (05) : 1006 - 1011
  • [45] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
    Hiramatsu, N
    Kasahara, A
    Nakanishi, F
    Toyama, T
    Tsujii, M
    Tsuji, S
    Kanto, T
    Takehara, T
    Kato, M
    Yoshihara, H
    Naito, M
    Katayama, K
    Hijioka, T
    Hagiwara, H
    Kubota, S
    Oshita, M
    Meren, H
    Masuzawa, M
    Haruna, Y
    Mita, E
    Suzuki, K
    Hayashi, N
    HEPATOLOGY RESEARCH, 2004, 29 (03) : 142 - 147
  • [46] Effect of a combination therapy with interferon and ofloxacin for chronic type C hepatitis; A multicenter randomized trial
    Takada, A
    Tsutsumi, M
    Sawada, M
    HEPATOLOGY, 1996, 23 (01) : P249 - P249
  • [47] Interferon-alpha and ribavirin versus interferon-alpha alone as therapy for chronic hepatitis C - A randomized double-blind placebo-controlled study.
    Reichard, O
    Norkrans, G
    Fryden, A
    Braconier, JH
    Alaeus, A
    Glaumann, H
    Schvarcz, R
    Sonnerborg, A
    Wejstal, R
    Weiland, O
    HEPATOLOGY, 1996, 24 (04) : 917 - 917
  • [48] The response rates in hepatitis C patients on interferon alpha and interferon+ribavirin combination therapy
    Muderrisoglu, Cuneyt
    Fincanci, Muzaffer
    Izat, Aylin
    Soysal, Ferda
    Boztas, Zeki
    Eren, Gulhan
    Polat, Hayri
    Dik, Iskender
    Sander, Ersan
    Gucin, Zuhal
    ISTANBUL MEDICAL JOURNAL, 2006, 7 (03): : 1 - 4
  • [49] High dose therapy with autoloous stem cell transplantation in aggressive NHL: Results of a randomized multicenter study.
    Kaiser, U
    Uebelacker, I
    Birkmann, J
    Havemann, K
    BLOOD, 1999, 94 (10) : 611A - 611A
  • [50] Interferon beta induction/interferon alpha therapy in patients with interferon-resistant chronic hepatitis C
    Watanabe, H
    Iwata, K
    Sohda, T
    Sakisaka, S
    HEPATOLOGY RESEARCH, 2002, 24 (04) : 355 - 360
12345